NORADRENALINE (NOREPINEPHRINE) EQUITY


concentrate for solution for infusion
scheduling status
S4
registration number
57/5.1/0871
What NORADRENALINE (NOREPINEPHRINE) EQUITY contains
Each mL of concentrate for solution for infusion contains 2 mg noradrenaline (norepinephrine) tartrate equivalent to 1 mg noradrenaline (norepinephrine) base. Each 4 mL ampoule contains 8 mg noradrenaline (norepinephrine) tartrate equivalent to 4 mg noradrenaline (norepinephrine) base. Each 8 mL ampoule contains 16 mg noradrenaline (norepinephrine) tartrate equivalent to 8 mg noradrenaline (norepinephrine) base.
other ingredients
Sodium chloride Hydrochloric acid or sodium hydroxide (qs pH 3,0 to 4,0) Water for injections.
Therapeutic classification
C01CA03,.
© 2026 SAHPRA. ALL RIGHTS RESERVED